Key facts
- This page summarizes Alan S. Roemer's Form 4 filing for NexImmune, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Nov 2023, 17:18.
Alan S. Roemer - 21 Nov 2023 Form 4 Insider Report for NexImmune, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 21 Nov 2023
- Net transaction value
- -$16,045
- SEC form
- 4
- Accepted by SEC
- 22 Nov 2023, 17:18:01 UTC
- Prior SEC filing
- 07 Jul 2023
- Next SEC filing
- 15 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/John Rudy, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan S. Roemer filed Form 4 for NexImmune, Inc. on 22 Nov 2023.
Change
- Previous filing in this sequence was filed on 07 Jul 2023.
- Current net transaction value: -$16,045.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEXI
transaction
Common Stock
Sale
- Transaction value
- $8,287
- Shares
- -3,833
- Change %
- -49%
- Price
- $2.16
- Shares after
- 3,992
- Date
- 21 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
NEXI
transaction
Common Stock
Sale
- Transaction value
- $7,758
- Shares
- -3,992
- Change %
- -100%
- Price
- $1.94
- Shares after
- 0
- Date
- 22 Nov 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.39 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.
Footnote F2
The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.05 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.